Conditions: Kidney Diseases Coronary Artery Disease
Keywords: regadenoson chronic kidney disease stage III chronic kidney disease stage IV renal impairment coronary artery disease
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 511
Healthy volunteers: no

Brief summary:
This study is intended to assess the safety and tolerance of regadenoson in subjects with renal impairment.

Detailed description:

Arms:
arm 1: Matching intravenous (IV) bolus injection arm 2: 0.4 mg/5 mL intravenous bolus injection

Interventions: intervention 1: Regadenoson intervention 2: Placebo
Intervention descriptions: intervention 1: IV intervention 2: IV

Protocol document: